Skip to main content

Research Repository

Advanced Search

Outputs (52)

The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007–2012)
Journal Article
Tomlinson, J. E., Byrne, E., Pusterla, N., Magdesian, K. G., Hilton, H. G., McGorum, B., …Johnson, A. L. (in press). The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007–2012). Journal of Veterinary Internal Medicine, 29(5), 1403-1409. https://doi.org/10.1111/jvim.13594

Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils
Journal Article
Aktan, I., Dunkel, B., & Cunningham, F. M. Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils. Veterinary Immunology and Immunopathology, 152(3-4), 209-217. https://doi.org/10.1016/j.vetimm.2012.12.007